TRIPS Council Compulsory Licensing Report Will Be Rx Focus Post-Doha
Executive Summary
The brandname pharmaceutical industry is focusing on a TRIPS Council report on local drug production capability in developing countries as the next key event in the interpretation of the compulsory licensing provisions in the World Trade Organization's Trade Related Aspects of Intellectual Property Rights agreement
You may also be interested in...
Trade Bill Pharmaceutical IP Provisions Could Impact Chile Negotiations
The impact of the intellectual property provisions of the fast-track trade bill will be tested in negotiations on economic pacts with Chile and Singapore
Trade Bill Pharmaceutical IP Provisions Could Impact Chile Negotiations
The impact of the intellectual property provisions of the fast-track trade bill will be tested in negotiations on economic pacts with Chile and Singapore
WTO Patent Declaration Supports Incentives For Rx Companies
The World Trade Organization declaration on pharmaceutical patents includes language encouraging developed countries to provide incentives to industry to improve public health in developing nations